Latest news for TEB Bancorp (OTC:TBBA) Stock

TEB Bancorp Inc through its subsidiary is involved in banking services. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one-to four-family residential real estate loans, multifamily residential real estate loans and commercial real estate loans, and, to a lesser extent, consumer loans, construction loans, land and development loans, and commercial and industrial loans.

TEB Bancorp Inc

Arweave's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">AR</a>) price has increased 4.35% over the past 24 hours to $31.35. Over the past week, AR has experienced an uptick of over 1.0%, moving from $31.61 to its current price. As it stands right now, the coin's all-time high is $89.24. 
The chart below compares the price movement and volatility for Arweave over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1721847605_0.png" alt="price_chart" />
The trading volume for the coin has tumbled 73.0% over the past week along with the circulating supply of the coin, which has fallen 0.0%. This brings the circulating supply to 65.45 million, which makes up an estimated 99.17% of its max supply of 66.00 million. According to our data, the current market cap ranking for AR is #50 at $2.05 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1721847606_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

Movers

Trading Ideas

Cryptocurrency Arweave Up More Than 4% In 24 hours

The National Health Service (NHS) has prescribed Novo Nordisk A/S&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) weight-loss drug Wegovy far less often than anticipated, struggling with a shortage of weight management clinics required to distribute the popular treatment.
Since its launch, the drug has been prescribed just 3,300 times, significantly below the 13,500 patients expected to receive it in its first year, according to a Financial Times <a target="_blank" href="https://www.ft.com/content/0b125a3c-6b82-4703-b8a8-e28f7f1aa3ea" rel="noreferrer noopener">analysis</a> of NHS England data.
Demand for Wegovy is set to increase following the Medicines and Healthcare Products Regulatory Agency&#8217;s (MHRA) approval for its use in reducing the risk of serious heart problems or strokes in <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39915631/britains-drug-regulator-approves-novo-nordisks-weight-loss-drug-wegovy-to-cut-heart-disease-risk-" rel="noreferrer noopener">overweight and obese adults</a>.
Despite this, the drug is in short supply internationally. The NHS has prioritized supplies of Ozempic, another drug by Novo Nordisk that uses the same active ingredient but is designated for type-2 diabetes, over Wegovy.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39864734/craze-for-ozempic-and-zepbound-for-weight-loss-leave-diabetic-patients-without-critical-glp-1-med" rel="noreferrer noopener">Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications</a>.
The shortfall in Wegovy prescriptions is also attributed to the lack of specialist NHS weight-loss services.
According to the National Institute of Health and Care Excellence (NICE) guidelines, the NHS can prescribe Wegovy through these services to people with a BMI over 35 or over 30 with another weight-related condition for up to two years.
However, there are only around 20 of these &#8220;tier 3&#8221; services across the U.K., with some NHS trusts reporting long waiting lists.
NHS prescriptions of Wegovy have increased each month since its approval in the U.K. last year, reaching approximately 770 in April.
This number is likely to rise further, with an estimated 4 million Britons expected to meet the drug guidelines by 2027.
NICE anticipates nearly 50,000 patients annually will receive semaglutide, the active ingredient in Wegovy, via the NHS.
Despite prioritizing Ozempic supply to ensure type-2 diabetes patients receive necessary treatment, citing Novo Nordisk, the FT report stated it has &#8220;made it a priority to provide a protected supply of Wegovy to the NHS.&#8221;
However, the company did not disclose the number of drugs available through the health service.
In the U.K., GLP-1 drugs, including Wegovy, are expected to be in short supply until at least the end of 2024.
Price Action: NVO shares are trading lower by 1.46% to $131.34 at the last check on Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39890609/oral-weight-loss-drugs-vs-injections-pills-are-promising-yet-challenging-frontier" target="_blank" rel="noreferrer noopener">Oral Weight Loss Drugs Vs. Injections &#8211; Pills Are Promising Yet Challenging Frontier</a>.</li>
</ul>
Photo by Tobias Arhelger via Shutterstock

Biotech

Large Cap

News

Eurozone

Health Care

Media

General

UK's NHS Prescribes Weight-Loss Drug Wegovy Less Than Expected Due To Service Shortages

Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) shares are trading lower&nbsp;after the company reported worse-than-<a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/39908857/comcasts-q2-earnings-studios-and-theme-parks-pull-revenue-lower-broadband-and-video-subs-fall" rel="noreferrer noopener">expected&nbsp;second-quarter sales results yesterday</a>.
The company reported a revenue decline of 2.7% year-over-year to $29.69 billion, missing the&nbsp;analyst consensus estimate of $30.02 billion and adjusted EPS of $1.21, beating&nbsp;analyst consensus estimates of $1.12.
BofA Securities analyst Jessica Reif Ehrlic reiterated a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/CMCSA/analyst-ratings" rel="noreferrer noopener">with a price target of $50</a>.
Although it&#8217;s early in the quarter and most ACP activity will be in the third quarter, the analyst is reducing the broadband net loss forecast to -150k from -165k due to positive customer response, Comcast&#8217;s targeted segmentation, and favorable seasonality.
Ehrlic revised the 2024 broadband net loss forecast to -415k (from -485k). For C&amp;P, revenue is expected to be flat (0.0%) with a 1.5% EBITDA increase (previously 1.3%), and C&amp;E revenue growth is revised to 2.1% (from 5%) with an 8% EBITDA decline (previously 2.8% growth) due to lower Theme Park and Media forecasts, especially from reduced Olympic profitability.
The analyst now projects 2024 EBITDA to be flat (previously 1.1% growth), EPS is updated to $4.20, and FCF is revised to $11.1 billion.
KeyBanc Capital Markets analyst Brandon Nispel reiterated the Overweight rating and lowered the price target to $44 from $45.
The analyst writes that near-term catalysts are elusive, with challenges in Theme Park growth and Peacock loss improvement due to lower domestic park attendance and the NBA contract.
Nispel writes that they remain positive on CMCSA&#8217;s efficient Broadband operations and modest growth, though short-term subscriber trends are challenging and recovery timelines are pushed out.
The analyst expects low-single-digit operating cash flow growth, reduced capital spending in 2025, and FCF growth (excluding one-time Hulu tax payments), which should lead to shareholder returns despite ongoing competitive challenges.
Oppenheimer analyst Timothy Horan reaffirmed the Outperform rating with a price target of $55.
The analyst writes that main concern is high broadband losses due to increasing FWA/fiber competition, impacting Video/Voice subscribers.
While the company offers aggressive bundled promotions, the analyst adds that it remains focused on FCF generation. He projects subscriber trends to remain volatile in the near term.
Investors can focus on the stock via Simplify Exchange Traded Funds Simplify Next Intangible Value Index ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/NXTV#BATS">NXTV</a>) and IShares U.S. Telecommunications ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IYZ#BATS">IYZ</a>).
Price Action: CMCSA shares are down 1.58% at $37.90 at the last check Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39904647/comcasts-paris-olympics-bet-for-boosting-peacocks-viewership-report" target="_blank" rel="noreferrer noopener">Comcast&#8217;s Paris Olympics Bet For Boosting Peacock&#8217;s Viewership: Report</a></li>
</ul>

Equities

Price Target

Reiteration

Analyst Ratings

CMCSA

iShares Dow Jones US Telecommunications Sector Index Fund

Simplify Exchange Traded Funds Simplify Next Intangible Value Index ETF

NXTV

Comcast Faces Headwinds: Analysts Adjust Expectations Amid Broadband Struggles and Theme Park Downturns

Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) shares are trading lower Wednesday as the <a href="https://www.benzinga.com/news/earnings/24/07/39933993/nasdaq-down-2-alphabet-posts-upbeat-earnings">broader market pulls back.&nbsp;</a>
The Details:
The Nasdaq Composite is trading lower by nearly 400 points Wednesday following <a href="https://www.benzinga.com/news/earnings/24/07/39932395/tesla-stock-is-sliding-wednesday-whats-going-on">disappointing earnings</a> from Tesla and Alphabet on Tuesday. Investors may be considering whether the mega cap tech stocks, including Meta, can continue to support a large percentage of the overall market's growth.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/07/39916480/whats-going-on-with-carnival-stock">What&#8217;s Going On With Carnival Stock?</a>
What Else:&nbsp;
Meta announced the launch of its latest version of its "Llama" AI software on Tuesday which the company touts as the first openly available model that rivals top AI models in general knowledge, steerability, math, tool use and multilingual translation.
Llama&#8217;s software is used to power "Meta AI" a chatbot <a href="https://www.benzinga.com/tech/24/07/39915337/mark-zuckerberg-takes-aim-at-elon-musk-sam-altman-with-big-ai-aspirations-through-metas-latest-llama">currently available</a> to users throughout Meta&#8217;s suite of applications, including Facebook, Instagram and WhatsApp.&nbsp;
In connection with Meta's latest Llama release, NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)<a href="https://www.benzinga.com/news/24/07/39915185/whats-going-on-with-nvidia-stock-tuesday"> announced a new </a>AI foundry and NIM inference microservices for the collection of openly available AI models.&nbsp;
"The new Llama 3.1 models are a super-important step for open source AI. With NVIDIA AI Foundry, companies can easily create and customize the state-of-the-art AI services people want and deploy them with NVIDIA NIM. I'm excited to get this in people's hands," said Mark Zuckerberg, founder and CEO of Meta.
<h2 class="wp-block-heading">META Stock Prediction 2024: </h2>
Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.
Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Meta Platforms, an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Meta Platforms, the 200-day moving average sits at $428.25, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, which is below the current price of $471.94. For more on charts and trend lines, <a href="https://pro.benzinga.com/">see a description here.</a>
Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.
META Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Meta Platforms shares are down 5.45% at $462.06 at the time of publication Wednesday. 
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39918051/texas-instruments-stock-climbs-on-q2-results-strong-forward-guidance">Texas Instruments Stock Climbs On Q2 Results, Strong Forward Guidance</a></li>
</ul>
Image: Shutterstock

NVDA

What's Going On With Meta Stock?

Editor&#8217;s note: This story has been updated to correct a misspelling of the word &#8220;steer.&#8221;
EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has crossed an important milestone on the way to rolling out its <a href="https://www.benzinga.com/general/entertainment/24/07/39870013/elon-musk-reacts-as-rapper-meek-mill-flexes-his-all-black-cybertruck-ahead-of-his-new-song-">stainless steel Cybertruck </a>in the neighboring country of Canada. 
What Happened: Canada granted the EV maker approval to use its steer-by-wire system in the country as required for testing. The technology, which does not meet the country&#8217;s specification for minimum steering angle, is only available on the company&#8217;s Cybertruck and not on any of its other offerings.
Tesla, however, will have to provide detailed semi-annual incident reports starting on January 18, the government said, while also meeting other regulatory demands.
&#8220;An important milestone on our way to Canada,&#8221; Cybertruck lead engineer Wes Morrill said about the green light from the Canadian government. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">An important milestone on our way to &#x1f1e8;&#x1f1e6;
&mdash; Wes (@wmorrill3) <a href="https://twitter.com/wmorrill3/status/1814491440359395602?ref_src=twsrc%5Etfw">July 20, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The Cybertruck is the latest offering from Tesla. The company started delivering the trucks to U.S. customers in late November. 
Former Tesla executive Rohan Patel <a href="https://www.benzinga.com/news/24/02/37304997/tesla-executive-sheds-light-on-cybertruck-availability-in-canada-have-to-file-some-routine-paperwork">confirmed earlier this year</a> that Tesla will indeed sell Cybertrucks in Canada. 
"No doubt we will sell Cybertruck in Canada- insanely huge interest,"&nbsp;Patel&nbsp;wrote on X, formerly Twitter.
"Have to file some routine paperwork, but hoping that can be wrapped up soon," he added. Patel was vice president of Public Policy and Business Development at Tesla. He left the company in April. 
Tesla&#8217;s Canadian website currently shows only an option to pre-order the Cybertruck for $150. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39870115/spacex-ceo-elon-musk-says-safe-destruction-of-international-space-station-will-be-a-very-dramatic-ev" target="_blank" rel="noreferrer noopener">SpaceX CEO Elon Musk Says Safe Destruction Of International Space Station Will Be A ‘Very Dramatic Event:&#8217; ‘Sky Full Of Shooting Stars&#8217;</a></li>
</ul>
Photo via Shutterstock

Tech

TSLA

Tesla Gets Green Light From Canadian Government To Deploy Steer-By-Wire System, Clearing Path For Cybertruck Sales (CORRECTED)

JMP Securities analyst Andrew Boone reiterates Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Market Outperform and maintains $200 price target.

GOOG

GOOGL

JMP Securities Reiterates Market Outperform on Alphabet, Maintains $200 Price Target

PGA Tour golfer Scottie Scheffler is soon to compete in his first Olympic games and hopes to get a win to complement his <a href="https://www.benzinga.com/general/sports-betting/24/05/38897634/jailbird-ie-scottie-scheffler-snags-dave-portnoys-support-post-arrest-through-the-bowels-o">strong 2024 season.</a>
What Happened: Scheffler <a href="https://www.benzinga.com/general/sports-betting/24/06/39279133/2024-us-open-how-to-watch-betting-odds-key-narratives-of-scottie-scheffler-tiger-woods-phi">has been dominant</a> in the 2024 PGA Tour season, winning six tournaments, including the Players Championship and the Masters.
In 16 events, Scheffler <a href="https://www.pgatour.com/player/46046/scottie-scheffler">made </a>16 cuts and 14 top-10 finishes. Along with his six wins, Scheffler also has two runner-up finishes.
Scheffler is one of four golfers representing the U.S. at the 2024 Summer Olympics. Along with Scheffler, Xander Schauffele, Wyndham Clark and Collin Morikawa will compete as members of Team USA.
The four golfers currently <a href="https://www.pgatour.com/stats/detail/186">rank </a>first, second, fifth and sixth in the PGA Tour rankings.
Here are the betting odds for the golfers in the 2024 Summer Olympics in Paris, France, with betting odds from DraftKings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dkng#NASDAQ">DKNG</a>).
Scheffler: +330
Schauffele: +600
Morikawa: +1,000
Clark: +4,000
Scheffler is the betting favorite and Schauffele is tied for second-best betting odds with Rory McIlroy (Ireland), who ranks third in PGA Tour rankings. Clark is further down the list. Ludvig Aberg (Sweden) has the fifth-best odds of +1,200 and ranks fourth in the PGA Tour rankings. A total of 60 men&#8217;s golfers will compete in the tournament at the Olympics.
Read Also: <a href="https://www.benzinga.com/news/22/04/26569375/scottie-scheffler-wins-the-masters-how-much-a-100-bet-on-the-golfer-paid-out-and-how-one-bettor-made">Scottie Scheffler Wins The Masters: How Much A $100 Bet On The Golfer Paid Out And How One Bettor Made As Much As Schef With A Single Bet</a>
Why It's Important: Golf was an Olympic sport in the 1900 and 1904 games before taking a 112-year break. The sport was brought back as an Olympic sport in 2016 and this year's Olympics will be the third straight games with the competition.
The men's tournament will be <a href="https://olympics.com/en/paris-2024/schedule/golf?day=1-august">held </a>from Aug. 1 through Aug. 4 with golfers competing for individual medals. Each day's competition takes place from 3 a.m. ET to 12 p.m. ET with Comcast Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) streaming the four days on Peacock.
American golfers have been dominant at the Olympics, <a href="https://www.nbcolympics.com/news/golf-101-olympic-history">winning </a>13 total medals and five gold medals in the past four Olympics, including men's and women's events.
Schauffele won a gold medal in the 2020 Summer Olympics and will look to defend his title. Morikawa finished fourth at the 2020 Summer Olympics, losing a bronze medal and third-place finish in a playoff.
Like Scheffler, Schauffele has been dominant in the 2024 PGA Tour season. The golfer <a href="https://www.pgatour.com/player/48081/xander-schauffele/results">made </a>18 cuts in 18 events and had two wins (PGA Championship, The Open Championship).
Scheffler and Schauffele are favorites for a reason and there is a good chance that at least one of them can add to America's Olympic medal count in the sport.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/23/08/34014067/more-than-a-game-athletes-rare-emotional-interview-reveals-human-side-of-professional-golf">More Than A Game: Athlete&#8217;s Rare, Emotional Interview Reveals Human Side Of Professional Golf</a></li>
</ul>
Photo: Quibix Studio via Shutterstock

Sports Betting

Sports

Events

Global

DKNG

Scottie Scheffler, Gold Medalist? Golfer Looks To Turn 2024 PGA Tour Success Into A 2024 Olympic Medal

As Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) gears up for its Q3 2024 earnings report, all eyes <a href="https://www.benzinga.com/quote/AAPL/news">are on Cupertino, California</a>.
According to JPMorgan analyst Samik Chatterjee, Apple is not just coasting on its past success but gearing up for a thrilling AI-driven future that could propel its stock to new heights. 
Chatterjee has placed Apple on a &#8216;Positive Catalyst Watch,&#8217; raising the price target to $265 by December 2025, up from the previous $245 for December 2024.
So, what's behind this optimistic outlook? Let's dive into the details.
<h3 class="wp-block-heading">AI is Apple&#8217;s Next Ace</h3>
According to Chatterjee, Apple is in a strong position to leverage this upcoming AI cycle, particularly through its iPhone and overall revenue performance. 
"We expect Apple to reassure investors that the upcoming AI replacement cycle earmarked to begin in earnest in FY25 (Sep-end), and step-up further into FY26, is leveraging a more robust launchpad in FY24 with better than expected revenue drivers," says Chatterjee.
He expects a revenue beat for both iPhone sales and the company&#8217;s total revenue, which could ease investor concerns about Apple&#8217;s premium valuation multiple. For the third quarter, Chatterjee anticipates Apple&#8217;s revenue to reach $85.3 billion, slightly above the consensus of $84.3 billion. Earnings per share are expected to be $1.38, compared to the consensus of $1.34.
<h3 class="wp-block-heading">iPhone To Be Key Apple Earnings&#8217; Driver</h3>
Notably, the iPhone is projected to be a key driver of this performance, with estimated sales of approximately 44 million units, leading to $39.9 billion in revenue, surpassing the consensus of $38.9 billion. Strong performance in China and other key regions is expected to contribute significantly to these numbers.
Looking ahead to the fourth quarter, Chatterjee forecasts revenue of $95.5 billion and earnings per share of $1.62, both ahead of the consensus estimates. This projection marks the second consecutive quarter of year-over-year revenue growth, following a decline earlier this year. 
The iPhone, Services, and Mac segments are expected to lead the charge, while the Wearables, Home, and Accessories segment might experience some decline.
Read Also: <a href="https://www.benzinga.com/news/large-cap/24/07/39937929/magnificent-7-still-comprise-over-30-of-s-p-500-despite-tech-correction">Magnificent 7 Still Comprise Over 30% Of S&amp;P 500 Despite Tech Correction</a>
<h3 class="wp-block-heading">Apple&#8217;s AI Cycle: Underestimated or Overlooked?</h3>
While Apple&#8217;s stock has rallied in recent months, Chatterjee sees room for further upside. He believes that the AI cycle presents untapped opportunities, particularly in improving margins, increasing iPhone volumes, and potentially extending the replacement cycle beyond FY26.
Chatterjee believes there is untapped potential within Apple&#8217;s AI strategy. He outlines three key areas that investors might be underestimating:
<ol>
<li>Margin Boost: The preference for premium iPhones among early adopters has historically led to impressive gross margin improvements, and this trend could continue despite investor concerns about component costs. </li>
<li>Volume Expansion: The AI-driven upgrade cycle is not confined to North America. Apple's reach could extend globally, driving volumes beyond expectations and marking a departure from the patterns seen in the 5G cycle. </li>
<li>Prolonged Growth: With leading-edge AI features slated for iPhones post-FY26, Apple might witness an extended period of growth, possibly outstripping current expectations.</li>
</ol>
As Chatterjee states, &#8220;Our Dec-2025 price target of $265 only assumes a 26x earnings multiple on CY26 estimates as they already embed the tailwinds of the AI replacement cycle.&#8221;
With these factors in play, Apple&#8217;s upcoming earnings release could be the spark needed to propel its stock to new heights.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39929189/elon-musk-agrees-with-mark-zuckerberg-on-apple-tesla-ceo-wonders-how-many-enemies-he-can-make-and-su">Elon Musk Agrees With Mark Zuckerberg On Apple, Tesla CEO Wonders How Many Enemies He Can Make And Survive</a></li>
</ul>

Analyst Color

Earnings

Previews

AAPL

Apple Q3 Earnings Preview: Will AI Elevate iPhone Maker's Stock?

Chipotle Mexican Grill Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) shares are in the spotlight Wednesday ahead of earnings after the bell. Here&#8217;s what <a href="https://www.benzinga.com/news/earnings/24/07/39883167/should-you-bet-on-chipotle-stock-ahead-of-q2-earnings">you need to know</a>.
What To Know: Chipotle is due to report financial results for the second quarter after the market close on Wednesday. Analysts expect the fast-casual restaurant chain company to report earnings of 32 cents per share and revenue of $2.939 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>. 
Last quarter, Chipotle <a href="https://www.benzinga.com/news/earnings/24/04/38417218/chipotle-mexican-grill-q1-earnings-revenue-beat-eps-beat-comparable-sales-up-7-and-more">beat analyst estimates</a> on the top and bottom lines as revenue jumped 14.1% year-over-year to $2.702 billion. Adjusted earnings of $13.37 per share came in ahead of analyst estimates of $11.68 per share.&nbsp;
Comparable restaurant sales increased 7% year-over-year due to higher transactions and a&nbsp;1.6%&nbsp;increase in average check and digital sales represented 36.5% of food and beverage revenue.
Chipotle continues to expect full-year 2024 comparable restaurant sales growth in the mid- to high-single-digit range.
Chipotle has met or exceeded analyst estimates on the top and bottom lines in three consecutive quarters heading into Wednesday&#8217;s print, per data from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/07/39883167/should-you-bet-on-chipotle-stock-ahead-of-q2-earnings">Should You Bet on Chipotle Stock Ahead of Q2 Earnings?</a>
Guggenheim analyst Gregory Francfort maintained Chipotle with a <a href="https://www.benzinga.com/analyst-stock-ratings">Neutral rating</a> on Wednesday and raised the price target from&nbsp;$54.50&nbsp;to&nbsp;$55. Here&#8217;s a look at other recent analyst changes leading up to earnings:
<ul>
<li>Barclays analyst Jeffrey Bernstein maintained Chipotle with an Equal-Weight rating and adjusted the price target to&nbsp;$58.</li>
</ul>
<ul>
<li>Piper Sandler analyst Brian Mullan maintained Chipotle with a Neutral and loweeds the price target from&nbsp;$61.40&nbsp;to&nbsp;$60.</li>
</ul>
<ul>
<li>Citigroup analyst Jon Tower maintained Chipotle with a Buy and raised the price target from&nbsp;$67.38&nbsp;to&nbsp;$71.</li>
</ul>
<ul>
<li>Stephens &amp; Co. analyst Jim Salera reiterated Chipotle with an Equal-Weight&nbsp;rating.</li>
</ul>
CMG Price Action: Chipotle shares were down 1.28% at $51.88 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39932008/tesla-to-rally-around-22-here-are-10-top-analyst-forecasts-for-wednesday">Tesla To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>
Photo: courtesy of Chipotle.

What's Going On With Chipotle Mexican Grill Stock Wednesday?

Barrington Research analyst Alexander Paris maintains Universal Technical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>) with a Outperform and raises the price target from $20 to $22.

Barrington Research Maintains Outperform on Universal Technical, Raises Price Target to $22

Barrington Research analyst Alexander Paris maintains Adtalem Glb Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NYSE">ATGE</a>) with a Outperform and raises the price target from $70 to $90.

Adtalem Global Education Inc. Common Stock

ATGE

Barrington Research Maintains Outperform on Adtalem Glb Education, Raises Price Target to $90

Alkermes (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alks#NASDAQ">ALKS</a>) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -1.37%. A quarter ago, it was expected that this drugmaker would post earnings of $0.59 per share when it actually produced earnings of $0.44, delivering a surprise of -25.42%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Alkermes, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $399.13 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 1.21%. This compares to year-ago revenues of $617.4 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Alkermes shares have lost about 9.9% since the beginning of the year versus the S&amp;P 500&#39;s gain of 16.5%.
What&#39;s Next for Alkermes?
While Alkermes has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Alkermes: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.79 on $392.26 million in revenues for the coming quarter and $2.67 on $1.51 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 34% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Arcellx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aclx#NASDAQ">ACLX</a>), is yet to report results for the quarter ended June 2024.
This company is expected to post quarterly loss of $0.54 per share in its upcoming report, which represents a year-over-year change of -8%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Arcellx, Inc.&#39;s revenues are expected to be $27.73 million, up 93.9% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2307547/alkermes-alks-lags-q2-earnings-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2307547">To read this article on Zacks.com click here.</a>

Earnings Misses

ACLX

ALKS

Alkermes Lags Q2 Earnings Estimates

Wedbush analyst Taz Koujalgi maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Outperform and lowers the price target from $385 to $315.

CRWD

Wedbush Maintains Outperform on CrowdStrike Holdings, Lowers Price Target to $315

Wedbush analyst Seth Basham reiterates Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Outperform and maintains $70 price target.

Wedbush Reiterates Outperform on Wayfair, Maintains $70 Price Target

Macquarie analyst Paul Golding maintains Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Outperform and maintains $300 price target.

Macquarie Maintains Outperform on Visa, Maintains $300 Price Target

Roper Technologies (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rop#NASDAQ">ROP</a>) came out with quarterly earnings of $4.48 per share, beating the Zacks Consensus Estimate of $4.46 per share. This compares to earnings of $4.12 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 0.45%. A quarter ago, it was expected that this industrial equipment maker would post earnings of $4.34 per share when it actually produced earnings of $4.41, delivering a surprise of 1.61%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Roper Technologies, which belongs to the Zacks Computers - IT Services industry, posted revenues of $1.72 billion for the quarter ended June 2024, missing the Zacks Consensus Estimate by 0.45%. This compares to year-ago revenues of $1.53 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Roper Technologies shares have added about 5.3% since the beginning of the year versus the S&amp;P 500&#39;s gain of 16.5%.
What&#39;s Next for Roper Technologies?
While Roper Technologies has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Roper Technologies: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $4.63 on $1.74 billion in revenues for the coming quarter and $18.17 on $6.92 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the top 42% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>), another stock in the same industry, has yet to report results for the quarter ended June 2024. The results are expected to be released on August 1.
This company is expected to post quarterly loss of $0.07 per share in its upcoming report, which represents a year-over-year change of +41.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
BigBear.ai Holdings, Inc.&#39;s revenues are expected to be $46.55 million, up 21% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2307533/roper-technologies-rop-surpasses-q2-earnings-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2307533">To read this article on Zacks.com click here.</a>

Earnings Beats

Penny Stocks

Small Cap

BBAI

Roper Technologies Surpasses Q2 Earnings Estimates

Wedbush analyst Seth Basham maintains Genuine Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) with a Neutral and lowers the price target from $170 to $145.

Wedbush Maintains Neutral on Genuine Parts, Lowers Price Target to $145

U.S. stocks traded lower toward the end of trading, with the S&amp;P 500 falling around 100 points on Wednesday.
The Dow traded down 0.82% to 40,025.48 while the NASDAQ fell 2.92% to 17,472.06. The S&amp;P 500 also fell, dropping, 1.84% to 5,453.67.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39932485/jim-cramer-calls-axsome-a-double-or-nothing-stock-says-sap-is-incredible">Jim Cramer Calls Axsome A &#8216;Double Or Nothing Stock,&#8217; Says SAP Is &#8216;Incredible&#8217;</a> 
Leading and Lagging Sectors Utilities shares jumped by 0.8% on Wednesday.
In trading on Wednesday, consumer discretionary shares fell by 3%.
Top Headline
Shares of AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) rose around 5% during Wednesday&#8217;s session following second-quarter earnings.
AT&amp;T reported fiscal second-quarter 2024 operating revenues of $29.8 billion, down 0.4% year over year and missing the analyst consensus estimate of $29.9 billion. Adjusted EPS of 57 cents is in line with the analyst consensus estimate, according to data from Benzinga Pro.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Pieris Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIRS#NASDAQ">PIRS</a>) shares shot up 78% to $14.15 after the company announced that the company entered into a definitive merger agreement with Palvella Therapeutics.</li>
<li>Shares of Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) got a boost, surging 47% to $0.5914 after licensing partner Pfizer&#8217;s Phase 3 AFFINE trial evaluating giroctocogene fitelparvovec met its primary endpoint.</li>
<li>PROG Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRG#NYSE">PRG</a>) shares were also up, gaining 21% to $42.02 after the company reported better-than-expected second-quarter financial results. Also, the company raised its FY24 guidance above estimates.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) shares dropped 76% to $1.1899 after the company announced the pricing of a $10 million public offering of 6,665,000 common shares and Class A warrants at $1.50 per share.</li>
<li>Shares of Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) were down 40% to $2.49 after the company announced the pricing of a $2 million public offering of 469,340 common shares at $4.24 a share.</li>
<li>Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) was down, falling 28% to $56.37 after the company reported worse-than-expected quarterly financial results. Also, the company issued its FY25 EPS guidance below estimates.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39929121/top-3-tech-and-telecom-stocks-that-are-set-to-fly-in-july">Top 3 Tech And Telecom Stocks That Are Set To Fly In July</a> 
Commodities In commodity news, oil traded up 1% to $77.72 while gold traded up 0.4% at $2,417.40.
Silver traded up 0.1% to $29.35 on Wednesday, while copper fell 1.2% to $4.1110.
Euro zone
European shares closed lower today. The eurozone's STOXX 600 fell 0.61%, Germany's DAX fell 0.92% and France's CAC 40 fell 1.12%. Spain's IBEX 35 Index fell 0.02%, while London's FTSE 100 fell 0.17%.
The HCOB Eurozone manufacturing PMI declined to 45.6 in July from 45.8 in June, while services PMI slipped to 51.9 from 52.8. The HCOB France composite PMI climbed to 49.5 in July from 48.8 in the prior month, while German composite PMI declined to 48.7 from 50.4.
The S&amp;P Global Flash UK manufacturing PMI rose to 51.8 in July from 50.9 in June, while services PMI rose to 52.4 in July from 52.1 in the previous month.
Asia Pacific Markets
Asian markets closed lower on Wednesday, with Japan's Nikkei 225 falling 1.11%, Hong Kong's Hang Seng Index falling 0.91%, China's Shanghai Composite Index declining 0.46% and India's S&amp;P BSE Sensex declining 0.35%.
The HSBC India Manufacturing PMI climbed to 58.5 in July from 58.3 the prior month, while services PMI rose to 61.1 in July from 60.5. The au Jibun Bank Flash Japan composite PMI rose to 52.6 in July versus a final reading of 49.7 in June.
Economics
<ul>
<li>U.S. mortgage applications declined by 2.2% in the latest week, compared to a 3.9% gain in the prior period.</li>
<li>The S&amp;P Global flash manufacturing PMI fell to 49.5 in July from 51.6 in June and compared to market estimates of 51.7.</li>
<li>The S&amp;P Global composite PMI climbed to 55.0 in July from 54.8 in the prior month.</li>
<li>The U.S. trade deficit in goods shrank to $96.84 billion in June versus a $99.37 billion gap in the earlier month.</li>
<li>Building permits increased by 3.9% to an annual rate of 1.454 million in June.</li>
<li>U.S. new home sales declined 0.6% month-over-month to an annualized rate of 617,000 in June.</li>
<li>The EIA said crude oil inventories in the U.S. declined by 3.741 million barrels in the week ended July 19, compared to market estimates of a 2.05 million decline.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/07/39932008/tesla-to-rally-around-22-here-are-10-top-analyst-forecasts-for-wednesday">Tesla To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday</a>

Commodities

Intraday Update

AZTR

NUWE

PIRS

SGMO

Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings

CFFI

C&F Financial Q2 EPS $1.50 Down From $1.84 YoY

Wedbush analyst Scott Devitt reiterates Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Outperform and maintains $570 price target.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

TEB Bancorp

News

Latest news for TEB Bancorp (OTC:TBBA) Stock